Sharmeen Uddin

676 total citations
7 papers, 498 citations indexed

About

Sharmeen Uddin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Plant Science. According to data from OpenAlex, Sharmeen Uddin has authored 7 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 2 papers in Plant Science. Recurrent topics in Sharmeen Uddin's work include Cancer Mechanisms and Therapy (4 papers), Melanoma and MAPK Pathways (3 papers) and Cancer therapeutics and mechanisms (1 paper). Sharmeen Uddin is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Melanoma and MAPK Pathways (3 papers) and Cancer therapeutics and mechanisms (1 paper). Sharmeen Uddin collaborates with scholars based in United States, Türkiye and United Kingdom. Sharmeen Uddin's co-authors include Christine A. Pratilas, Neal Rosen, Kwok‐Kin Wong, Chunxiao Xu, Atsuko Ogino, Nathanael S. Gray, Pasi A. Jänne, Dalia Ercan, Marzia Capelletti and Geoffrey L. Greene and has published in prestigious journals such as PLoS ONE, Cancer Research and Cancer Discovery.

In The Last Decade

Sharmeen Uddin

7 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharmeen Uddin United States	5	263	247	238	149	130	7	498
Alessio Schirone Italy	12	124 0.5×	242 1.0×	173 0.7×	144 1.0×	52 0.4×	22	432
Sylvia De Brakeleer Belgium	12	317 1.2×	142 0.6×	104 0.4×	105 0.7×	147 1.1×	17	466
Cristina Hernándo Spain	13	188 0.7×	196 0.8×	114 0.5×	178 1.2×	72 0.6×	46	414
Carla L. Alves Denmark	9	165 0.6×	200 0.8×	188 0.8×	120 0.8×	50 0.4×	20	373
Fernando J. López-Díaz United States	8	357 1.4×	154 0.6×	115 0.5×	103 0.7×	53 0.4×	15	499
Aliaksandra Samoila United States	7	232 0.9×	319 1.3×	337 1.4×	359 2.4×	126 1.0×	11	586
Anne U. Goeppert United Kingdom	5	191 0.7×	149 0.6×	130 0.5×	110 0.7×	137 1.1×	5	357
Patricia Sung United States	7	275 1.0×	281 1.1×	286 1.2×	299 2.0×	131 1.0×	12	568
Hannah F. Wingate United States	10	226 0.9×	326 1.3×	128 0.5×	95 0.6×	52 0.4×	15	467
Lisa D. Eli United States	12	299 1.1×	318 1.3×	126 0.5×	70 0.5×	23 0.2×	26	549

Countries citing papers authored by Sharmeen Uddin

Since Specialization

Citations

This map shows the geographic impact of Sharmeen Uddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmeen Uddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmeen Uddin more than expected).

Fields of papers citing papers by Sharmeen Uddin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmeen Uddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmeen Uddin. The network helps show where Sharmeen Uddin may publish in the future.

Co-authorship network of co-authors of Sharmeen Uddin

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmeen Uddin. A scholar is included among the top collaborators of Sharmeen Uddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmeen Uddin. Sharmeen Uddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Uddin, Sharmeen, Nataliya Melnyk, & David A. Foster. (2020). Albumin promotes the progression of fibroblasts through late G₁ into S-phase in the absence of growth factors. Cell Cycle. 19(17). 2158–2167. 5 indexed citations

2.

Allen, Amy N., Alice Can Ran Qin, Nitya Raj, et al.. (2019). Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition. PLoS ONE. 14(6). e0217399–e0217399. 13 indexed citations

3.

Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). A Secondary Mutation in BRAF Confers Resistance to RAF Inhibition in a BRAF V600E-Mutant Brain Tumor. Cancer Discovery. 8(9). 1130–1141. 49 indexed citations

4.

Wang, Jiawan, Zhan Yao, Philip Jonsson, et al.. (2018). Abstract 3184: A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor. Cancer Research. 78(13_Supplement). 3184–3184. 1 indexed citations

5.

Uddin, Sharmeen, Peter A. Segun, Sezgin Çeli̇k, et al.. (2017). Flavonoids from two Turkish Centaurea species and their chemotaxonomic implications. Liverpool John Moores University. 1(4). 243–248. 2 indexed citations

6.

Toy, Weiyi, Hazel M. Weir, Pedram Razavi, et al.. (2016). Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists. Cancer Discovery. 7(3). 277–287. 269 indexed citations

7.

Xu, Chunxiao, Sharmeen Uddin, Marzia Capelletti, et al.. (2015). Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR -Mutant Lung Cancer. Cancer Discovery. 5(9). 960–971. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact